Study of Nalbuphine ER in Participants With Hepatic Impairment
Clinical trial NCT04020016 · COMPLETED
Trial details
- NCT number
- NCT04020016
- Sponsor
- Trevi Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-12
- Primary completion
- 2020-02-05
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.